Across TCGA pan-cancer cohorts, GAPDHP55 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated GAPDHP55 data layer.
The strongest signal is observed in mesothelioma (MESO), where higher GAPDHP55 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP55 expression acts as an unfavorable survival marker, although some lineages such as READ and CESC show a favorable association.
MESO, KIRP, and THYM are the cancer types where GAPDHP55 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.